REQUEST A DEMO
Total
USD $0.00
Search more companies

Cpc Citologia Y Patologia Del Caribe S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Cpc Citologia Y Patologia Del Caribe S.A.S. Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Cpc Citologia Y Patologia Del Caribe S.A.S. is based in Colombia, with the head office in Santa Marta. It operates in the Diagnostic Imaging Centers industry. The enterprise was incorporated on July 12, 2012. From the latest financial highlights, Cpc Citologia Y Patologia Del Caribe S.A.S. reported a net sales revenue drop of 16.27% in 2023. Its’ total assets recorded a negative growth of 8.72%. The net profit margin of Cpc Citologia Y Patologia Del Caribe S.A.S. increased by 7.18% in 2023.

Headquarters
Cll 22 N. 14 70 Lc 1 Perla Del Caribe
Santa Marta; Magdalena;

Contact Details: Purchase the Cpc Citologia Y Patologia Del Caribe S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Cpc Citologia Y Patologia Del Caribe S.A.S. report to view the information.
Incorporation Date:
July 12, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Cpc Citologia Y Patologia Del Caribe S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-16.27%
Total operating revenue
-16.27%
Operating profit (EBIT)
37.27%
Net Profit (Loss) for the Period
42.21%
Total assets
-8.72%
Total equity
-8.45%
Operating Profit Margin (ROS)
7.04%
Net Profit Margin
7.18%
Return on Equity (ROE)
5.86%
Quick Ratio
30.48%
Cash Ratio
5.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?